GO:1990712 HFE-transferrin receptor complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990712 describes a plasma membrane protein complex containing HFE and a transferrin receptor (TFR1/TFRC or TFR2) that senses transferrin-bound iron (Fe2-Tf) to regulate hepcidin transcription.
• The complex is built on the crystal structure of HFE bound to transferrin receptor 1, which revealed a high-affinity interaction that competes with transferrin binding.
• HFE co-traffics with transferrin receptor 1 and can alter receptor endocytosis and phosphorylation, linking the complex to intracellular iron regulation.
• Deletion of HFE or transferrin receptor 2 differentially modifies iron phenotypes in mice lacking BMP6 or hemojuvelin, showing the complex operates within the BMP-SMAD hepcidin regulatory axis.
• HFE variants, including complex alleles such as HFE c.[187C>G;340+4T>C], are associated with increased risk of iron overload in human populations.
• The HFE-transferrin receptor complex is a tractable target for peptide inhibitors and CRISPR-engineered cell models aimed at dissecting iron-sensing mechanisms.
Description
The HFE-transferrin receptor complex (GO:1990712) is a plasma membrane protein assembly that contains at least HFE and a transferrin receptor, either TFR1/TFRC or TFR2, and is proposed to sense transferrin-bound iron (Fe2-Tf) to regulate hepcidin transcription. This complex sits at the intersection of systemic iron homeostasis and cellular iron uptake, because transferrin receptors mediate iron-loaded transferrin endocytosis while HFE modulates this process. The crystal structure of HFE bound to transferrin receptor 1 provided the first molecular view of the complex and showed that HFE and transferrin compete for overlapping binding surfaces on the receptor. Researchers study GO:1990712 because its components are genetically linked to hereditary hemochromatosis and because the complex provides a mechanistic entry point for understanding how the liver senses iron status and adjusts hepcidin, the master hormone of iron absorption. Experimental work has shown that HFE co-traffics with transferrin receptor 1 and can abrogate receptor endocytosis by inducing receptor phosphorylation, indicating that the complex is not merely a static binding pair but a dynamic regulator of receptor trafficking. In parallel, mouse genetics has demonstrated that deletion of HFE or transferrin receptor 2 differentially impacts iron phenotypes in animals lacking BMP6 or hemojuvelin, placing the complex within the BMP-SMAD signaling network that controls hepcidin transcription. Together, these findings make GO:1990712 a focal point for studies of iron overload disorders, erythropoiesis, and the molecular logic of iron sensing.
HFE-transferrin receptor complex At A Glance
| GO ID | GO:1990712 |
|---|---|
| GO term | HFE-transferrin receptor complex |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Sensing of transferrin-bound Fe (Fe2-Tf) at the plasma membrane to regulate hepcidin transcription |
| Key components | HFE plus a transferrin receptor (TFR1/TFRC or TFR2) |
| Subcellular location | Plasma membrane, with co-trafficking through endosomal compartments |
| Related pathway | BMP-SMAD hepcidin regulatory axis |
| Disease relevance | Hereditary hemochromatosis and iron overload phenotypes |
What Is GO:1990712?
GO:1990712, the HFE-transferrin receptor complex, is a cellular component defined as a protein complex containing at least HFE and a transferrin receptor, either TFR1/TFRC or TFR2. It is proposed to play a role in sensing transferrin-bound Fe (Fe2-Tf) at the plasma membrane to regulate hepcidin transcription. In practical terms, it is a membrane-associated assembly in which the nonclassical MHC class I protein HFE engages a transferrin receptor, and this interaction is thought to convert extracellular iron signals into intracellular signals that control hepcidin gene expression.
Why Is HFE-transferrin receptor complex Important in Cell Biology?
GO:1990712 matters because it provides a molecular explanation for how the body senses iron-loaded transferrin and adjusts hepcidin, the hormone that controls dietary iron absorption and iron release from macrophages. The complex is directly implicated in hereditary hemochromatosis, where HFE variants cause inappropriate hepcidin suppression and progressive iron overload. Because the complex includes either TFR1 or TFR2, it also connects systemic iron sensing to cellular iron uptake and receptor trafficking, processes that are relevant to erythropoiesis and to diseases of iron maldistribution. For researchers, the complex offers a defined biochemical entity for structural, genetic, and pharmacological studies, including the design of peptide inhibitors that disrupt HFE-transferrin receptor 1 binding.
• Provides a mechanistic model for transferrin-bound iron sensing at the plasma membrane.
• Links HFE, the gene most commonly mutated in hereditary hemochromatosis, to transferrin receptor biology.
• Connects iron sensing to hepcidin transcription, the central control node of systemic iron homeostasis.
• Explains how HFE can alter transferrin receptor endocytosis and phosphorylation.
• Places HFE and TFR2 within the BMP6/hemojuvelin signaling network that controls hepcidin.
• Supports genetic studies of HFE complex alleles and iron overload risk in human populations.
• Offers a target for peptide inhibitors that block HFE-TFR1 interaction.
• Enables CRISPR-based dissection of iron-sensing mechanisms in hepatic and erythroid cell models.
• Relevant to understanding iron metabolism regulation in health and disease.
What Happens During HFE-transferrin receptor complex?
Assembly of HFE with transferrin receptor at the plasma membrane
In simple terms: HFE and a transferrin receptor find each other and stick together on the cell surface.
The HFE-transferrin receptor complex forms when HFE binds with high affinity to transferrin receptor 1, an interaction visualized in the crystal structure of the HFE-TFR1 complex. HFE is a nonclassical MHC class I protein that co-traffics with the transferrin receptor, implying that assembly occurs along the secretory and endosomal pathways before the complex reaches the plasma membrane. The complex can contain either TFR1/TFRC or TFR2, and the choice of receptor partner is thought to influence the functional output of the complex.
Competition with transferrin binding and iron sensing
In simple terms: HFE and iron-loaded transferrin compete for the same spot on the receptor, so the complex can sense how much iron is around.
Structural and biochemical studies showed that HFE and transferrin compete for overlapping binding sites on transferrin receptor 1, which provides a physical basis for iron sensing. Because transferrin-bound Fe (Fe2-Tf) is the physiological ligand, the occupancy of the receptor by HFE versus transferrin can report extracellular iron status. This competition is proposed to translate into changes in hepcidin transcription, the downstream output of the complex.
Modulation of transferrin receptor endocytosis and phosphorylation
In simple terms: When HFE binds the receptor, it can change how the receptor is recycled and tagged inside the cell.
HFE abrogates endocytosis of the transferrin receptor by inducing receptor phosphorylation, identifying a post-binding regulatory step in complex function. Co-trafficking of HFE with the transferrin receptor further supports a role in intracellular iron regulation rather than a purely surface-restricted interaction. These events link complex assembly to altered receptor trafficking and downstream signaling.
Integration with BMP-SMAD hepcidin regulation
In simple terms: The complex feeds into the liver signaling pathway that turns hepcidin production up or down.
Mouse genetic studies showed that deletion of HFE or transferrin receptor 2 differentially impacts the iron phenotype of mice lacking BMP6 or hemojuvelin, placing the complex within the BMP-SMAD pathway that controls hepcidin transcription. This integration means the complex does not act in isolation but modulates a signaling cascade that includes BMP6 and hemojuvelin. The net effect is context-dependent regulation of hepcidin and systemic iron balance.
Key Genes Involved in GO:1990712 HFE-transferrin receptor complex
The following genes and proteins are the principal components and modifiers of the HFE-transferrin receptor complex (GO:1990712) as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HFE | Nonclassical MHC class I protein that binds transferrin receptor and forms the core of the complex | Central to hereditary hemochromatosis and iron sensing |
| TFRC (TFR1) | Transferrin receptor 1 that binds HFE and mediates transferrin-bound iron uptake | Structural and trafficking studies of the complex |
| TFR2 | Transferrin receptor 2 that can partner with HFE in the complex | Differential iron phenotypes in mouse models |
| BMP6 | BMP ligand that controls hepcidin transcription and interacts genetically with HFE and TFR2 | Epistasis studies with HFE and TFR2 deletions |
| HJV (hemojuvelin) | BMP co-receptor required for hepcidin regulation and modified by HFE/TFR2 loss | Mouse genetics of iron overload |
| HAMP (hepcidin) | Downstream hormone whose transcription is regulated by the complex | Readout of complex activity |
| TF (transferrin) | Iron carrier whose binding competes with HFE on TFR1 | Biochemical competition assays |
| B2M | Beta-2-microglobulin associated with MHC class I-like HFE folding | Protein stability and trafficking studies |
| SLC40A1 (ferroportin) | Iron exporter regulated by hepcidin downstream of the complex | Functional iron flux assays |
| SMAD1/5/8 | Signal transducers downstream of BMP signaling that control hepcidin | Pathway epistasis experiments |
| HFE complex allele c.[187C>G;340+4T>C] | Variant haplotype associated with increased iron overload risk | Population genetics of iron overload |
| TFR1 phosphorylation sites | Post-translational modifications induced by HFE that affect endocytosis | Phosphorylation and trafficking assays |
| HFE-TFR1 interface residues | Structural determinants of HFE binding and competition with transferrin | Peptide inhibitor design |
| Peptide inhibitors of HFE-TFR1 | Engineered molecules that disrupt the complex | Chemical biology and therapeutic development |
| Iron metabolism regulators | General regulators of systemic iron homeostasis | Background for complex function |
How Is HFE-transferrin receptor complex Regulated?
The HFE-transferrin receptor complex is regulated at multiple levels. Its assembly depends on HFE binding to transferrin receptor 1, which competes with transferrin and is sensitive to iron status. HFE can induce phosphorylation of the transferrin receptor and abrogate its endocytosis, providing a post-translational regulatory mechanism. Genetically, the complex operates within the BMP-SMAD hepcidin pathway, where BMP6 and hemojuvelin modulate the consequences of HFE or TFR2 loss. Population-level variation in HFE, such as the complex allele HFE c.[187C>G;340+4T>C], further modifies iron overload risk, indicating that genetic context regulates complex-related phenotypes.
HFE-transferrin receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HFE | Hereditary hemochromatosis and iron overload | HFE knockout or point-mutation hepatic cell lines |
| TFR2 | Iron overload phenotypes modified by BMP6 or hemojuvelin loss | TFR2 knockout mouse or cell models |
| BMP6 | Hepcidin regulation and iron loading | BMP6/HFE double-knockout models |
| HJV | Juvenile hemochromatosis pathway interaction | HJV/HFE double-knockout models |
| HAMP (hepcidin) | Central iron regulatory hormone | Hepcidin reporter cell lines |
Hereditary hemochromatosis and iron overload
HFE is the gene most commonly associated with hereditary hemochromatosis, and the HFE-transferrin receptor complex provides a molecular explanation for how HFE variants lead to inappropriate hepcidin suppression and progressive iron overload. Carriers of the complex allele HFE c.[187C>G;340+4T>C] have increased risk of iron overload in the São Miguel Island population, illustrating how allelic complexity at HFE modifies disease risk. The complex therefore serves as a mechanistic link between HFE genotype and clinical iron overload.
Disorders of hepcidin regulation
Because the complex is proposed to regulate hepcidin transcription, its dysfunction can perturb the BMP-SMAD signaling network that includes BMP6 and hemojuvelin. Mouse studies show that deletion of HFE or transferrin receptor 2 differentially impacts iron phenotypes in animals lacking BMP6 or hemojuvelin, demonstrating that the complex interacts genetically with hepcidin-regulatory pathways. These findings are relevant to iron-loading anemias and conditions characterized by hepcidin dysregulation.
Iron metabolism in broader physiology
The complex sits within systemic iron metabolism, where transferrin-bound iron is delivered to cells and hepcidin controls iron export and absorption. Understanding the complex helps explain how the body balances iron uptake and storage, a process relevant to erythropoiesis and to diseases of iron maldistribution. The regulation of iron metabolism has been reviewed as a central physiological problem in which HFE and transferrin receptors play key roles.
From HFE-transferrin receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HFE alter hepcidin transcription? | HFE knockout hepatic cell line |
| Does a specific HFE variant change transferrin receptor binding? | HFE point-mutation knock-in cell model |
| Can a tagged HFE be used to track complex assembly? | Tagged HFE knock-in cell line |
| Does TFR2 substitution change complex function? | TFR2 knock-in or knockout cells |
| Can overexpression of HFE disrupt transferrin receptor endocytosis? | HFE overexpression cell model |
| Can peptide inhibitors block HFE-TFR1 interaction? | HFE-TFR1 binding assay with engineered peptides |
How to Study the HFE-transferrin receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Atomic structure of HFE-TFR1 complex | Mapping binding interface and transferrin competition |
| Surface plasmon resonance | Binding affinity between HFE and transferrin receptor | Testing peptide inhibitors |
| Phosphorylation immunoblot | Transferrin receptor phosphorylation induced by HFE | Assessing post-translational regulation |
| Co-trafficking imaging | Subcellular co-localization of HFE and transferrin receptor | Studying intracellular iron regulation |
| Mouse epistasis | Iron phenotype in compound knockout animals | Placing complex in BMP-SMAD pathway |
| Hepcidin reporter assay | Hepcidin transcription activity | Functional readout of complex signaling |
| Genotyping and association | HFE variant frequency and iron overload risk | Population genetics of hemochromatosis |
| Iron metabolism profiling | Systemic iron parameters | Contextualizing complex function |
Structural and biochemical analysis of the complex
Crystal structure determination of HFE bound to transferrin receptor 1 revealed the molecular interface and competition with transferrin, providing a template for mutational and inhibitor studies. Biochemical binding assays can quantify HFE-TFR1 affinity and the effect of engineered peptide inhibitors. These methods define the physical basis of complex assembly and iron sensing.
Cell trafficking and phosphorylation assays
Co-trafficking of HFE with the transferrin receptor can be monitored by imaging and biochemical fractionation, while receptor phosphorylation and endocytosis are measured to assess HFE-induced changes. These assays link complex formation to intracellular iron regulation. They are useful for testing point mutations that alter trafficking.
Genetic epistasis in mouse models
Deletion of HFE or transferrin receptor 2 in mice lacking BMP6 or hemojuvelin reveals differential impacts on iron phenotype, a classic epistasis approach to place the complex in the hepcidin pathway. Such models connect complex components to systemic iron parameters. They also help interpret human HFE variant phenotypes.
Population genetics and variant analysis
Studies of HFE complex alleles, such as c.[187C>G;340+4T>C], use genotyping and association analysis to link complex-related variants to iron overload risk. These approaches complement functional assays by identifying clinically relevant alleles. They also inform the design of knock-in models carrying patient variants.
How CRISPR Can Be Used to Study GO:1990712 HFE-transferrin receptor complex
Knockout
CRISPR knockout of HFE or TFRC/TFR2 can eliminate complex components and reveal their contribution to hepcidin transcription and iron handling. Knockout cell lines provide clean backgrounds for testing whether a candidate gene is required for complex function. Mouse knockout studies of HFE and TFR2 already demonstrate differential iron phenotypes that can be recapitulated in cellular models.
Point Mutation
Point-mutation knock-in of HFE variants, including clinically observed alleles, allows precise testing of how single amino acid or splice changes alter complex assembly and signaling. Such models are essential for distinguishing pathogenic from benign variants in iron overload. They also enable structure-function studies guided by the HFE-TFR1 crystal structure.
Knock-in
Knock-in of tagged HFE or TFR2 enables tracking of complex assembly, trafficking, and turnover in live cells. Tagged knock-in models preserve endogenous regulation while providing a handle for imaging and proteomics. They are particularly useful for studying co-trafficking with the transferrin receptor.
Overexpression
Overexpression of HFE or transferrin receptor components can amplify complex formation and reveal dominant effects on receptor endocytosis and phosphorylation. Overexpression models are useful for biochemical purification of the complex and for testing peptide inhibitors. They complement loss-of-function approaches by probing sufficiency.
How EDITGENE Supports HFE-transferrin receptor complex Research
Researchers studying HFE-transferrin receptor complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, iron sensing, or hepcidin regulation. EDITGENE provides CRISPR-engineered cell models and screening services that let teams move from correlation to causation with validated knockout, point-mutation, knock-in, and overexpression lines.
Contact EDITGENE today to design your custom CRISPR model for HFE-transferrin receptor complex research.
Frequently Asked Questions About HFE-transferrin receptor complex
What is GO:1990712?
GO:1990712 is the HFE-transferrin receptor complex, a cellular component containing at least HFE and a transferrin receptor (TFR1/TFRC or TFR2) that is proposed to sense transferrin-bound iron and regulate hepcidin transcription.
What genes are involved in the HFE-transferrin receptor complex?
The core genes are HFE and a transferrin receptor gene, TFRC (TFR1) or TFR2, with modifiers including BMP6, HJV, and HAMP in the hepcidin pathway.
Where is the HFE-transferrin receptor complex located?
The complex is found at the plasma membrane and co-traffics through intracellular compartments with the transferrin receptor.
What does the HFE-transferrin receptor complex do?
It is proposed to sense transferrin-bound Fe (Fe2-Tf) at the plasma membrane and regulate hepcidin transcription, linking iron status to systemic iron homeostasis.
How does HFE interact with transferrin receptor 1?
HFE binds transferrin receptor 1 with high affinity, and the crystal structure shows that HFE and transferrin compete for overlapping binding sites.
Does HFE affect transferrin receptor endocytosis?
Yes, HFE abrogates endocytosis of the transferrin receptor by inducing receptor phosphorylation.
What diseases are linked to the HFE-transferrin receptor complex?
Hereditary hemochromatosis and iron overload disorders are linked to HFE variants and complex dysfunction.
How is the complex related to hepcidin?
The complex is proposed to regulate hepcidin transcription and interacts genetically with the BMP6 and hemojuvelin pathway that controls hepcidin.
Can the HFE-transferrin receptor complex be targeted therapeutically?
Engineered peptide inhibitors of the HFE-transferrin receptor 1 complex have been developed, suggesting the complex is a tractable target.
What model systems are used to study GO:1990712?
Knockout and knock-in cell lines, mouse epistasis models, and biochemical binding assays are commonly used.
Conclusion
GO:1990712, the HFE-transferrin receptor complex, is a defined cellular component that connects HFE and transferrin receptor biology to the sensing of transferrin-bound iron and the regulation of hepcidin transcription. Its structural basis, trafficking behavior, and genetic interactions with the BMP-SMAD pathway make it a central node in iron homeostasis and a relevant target in hereditary hemochromatosis and iron overload. Continued work using CRISPR-engineered models and biochemical assays will clarify how complex assembly and variant-specific changes translate into clinical phenotypes.
References
- 1. Goncalves Monteiro D et al.. 2022. Engineering Peptide Inhibitors of the HFE-Transferrin Receptor 1 Complex.. Molecules 27(19) PMID: 36235117
- 2. Lebrón JA et al.. 1998. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.. Cell 93(1):111-23 PMID: 9546397
- 3. Salter-Cid L et al.. 2000. The major histocompatibility complex-encoded class I-like HFE abrogates endocytosis of transferrin receptor by inducing receptor phosphorylation.. Genes Immun 1(7):409-17 PMID: 11196670
- 4. Gross CN et al.. 1998. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation.. J Biol Chem 273(34):22068-74 PMID: 9705350
- 5. Latour C et al.. 2016. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.. Hepatology 63(1):126-37 PMID: 26406355
- 6. Roy CN et al.. 2000. Iron homeostasis: new tales from the crypt.. Blood 96(13):4020-7 PMID: 11110669
- 7. Branco CC et al.. 2015. Carriers of the Complex Allele HFE c.[187C>G;340+4T>C] Have Increased Risk of Iron Overload in São Miguel Island Population (Azores, Portugal).. PLoS One 10(10):e0140228 PMID: 26501199
- 8. Borch-Iohnsen B et al.. 2009. [Regulation of the iron metabolism].. Tidsskr Nor Laegeforen 129(9):858-62 PMID: 19415084
